Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A

7(87.5%)

Phase 1

1(12.5%)

8Total

N/A(7)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07089615Not ApplicableRecruiting

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

Role: lead

NCT04607746Not ApplicableCompleted

Pivotal Study of the CapsoCam Colon (CV-3) in Detecting Colonic Polyps, Using Colonoscopy as the Reference

Role: lead

NCT06916845Not ApplicableCompleted

Data Collection for CV-3E AI Software Development

Role: lead

NCT01820182Not ApplicableCompleted

Prospective Comparison of the Diagnostic Yield of Small Bowel Pillcam SB2 and Capsocam Capsule

Role: collaborator

NCT04246632Not ApplicableCompleted

CapsoCam® Colon Capsule Endoscope (CCE) Compared to Colonoscopy (OC)

Role: lead

NCT04573959Not ApplicableCompleted

Validation of CapsoVision CapsoCam® SV-3 Capsule Endoscopy System

Role: lead

NCT03685903Phase 1Unknown

Study for the Detection of Duodenal Papilla Using Capsule Endoscopy and Comparison of Images With EUS/ERCP Procedure.

Role: lead

NCT01787825Not ApplicableCompleted

Comparison of Capso Vision SV-1 to PillCam SB2 in the Evaluation of Subjects With Suspected Small Bowel Disease

Role: lead

All 8 trials loaded